Outset Medical (OM) Restructuring Costs (2024)

Outset Medical (OM) posted quarterly Restructuring Costs of $1.5 million for Q4 2024, up 7.14% quarter-over-quarter from $1.4 million in Q3 2024.

Outset Medical (OM) Restructuring Costs (2024) Analysis & Trends

Outset Medical (OM) has reported Restructuring Costs for 1 consecutive years, with $1.5 million the latest figure, recorded in Q4 2024.

In Q4 2024, Restructuring Costs changed N/A year-over-year to $1.5 million; the TTM figure through Dec 2024 stood at $5.6 million (changed N/A YoY), while the FY2024 annual figure was $1.5 million, down 40.0% from the prior year.
Restructuring Costs rose to $1.5 million in Q4 2024 per OM's latest filing, from $1.4 million in the prior quarter.
Across five years, Restructuring Costs topped out at $2.7 million in Q1 2024 and bottomed at $1.4 million in Q3 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	199.70 Bn	194.09 Bn	7.27 Bn
2	Stryker	127.31 Bn	123.83 Bn	4.50 Bn
3	Medtronic	118.93 Bn	109.71 Bn	6.41 Bn
4	Boston Scientific	73.35 Bn	72.82 Bn	3.85 Bn
5	Edwards Lifesciences	52.11 Bn	47.86 Bn	1.35 Bn
6	Dexcom	34.35 Bn	32.40 Bn	830.00 Mn
7	GE HealthCare Technologies	33.76 Bn	31.65 Bn	2.18 Bn
8	Koninklijke Philips	26.35 Bn	23.03 Bn	4.55 Bn
9	Steris	23.05 Bn	22.56 Bn	684.20 Mn
10	Outset Medical	80.62 Mn	-182.57 Mn	13.28 Mn

Download Data